These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23086971)

  • 41. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Fox K; Ford I; Steg PG; Tendera M; Ferrari R;
    Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
    Buus NH; Jørgensen CG; Mulvany MJ; Sørensen KE
    Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
    Chello M; Goffredo C; Patti G; Candura D; Melfi R; Mastrobuoni S; Di Sciascio G; Covino E
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):805-10. PubMed ID: 16274999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].
    Chen H; Ren JY; Wu B; Liu X; Wang RJ; Li LJ; Luo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):531-5. PubMed ID: 17711713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure.
    Komajda M; Böhm M; Borer J; Ford I; Krum H; Tase A; Tavazzi L; Swedberg K
    Eur J Heart Fail; 2013 Jan; 15(1):79-84. PubMed ID: 22892123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Terminalia arjuna reverses impaired endothelial function in chronic smokers.
    Bharani A; Ahirwar LK; Jain N
    Indian Heart J; 2004; 56(2):123-8. PubMed ID: 15377133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke.
    Chan YH; Lau KK; Yiu KH; Li SW; Chan HT; Fong DY; Tam S; Lau CP; Tse HF
    Eur Heart J; 2008 Nov; 29(22):2800-7. PubMed ID: 18812325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
    Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a technique to measure heart rate variability in anaesthetised cats.
    Khor KH; Shiels IA; Campbell FE; Greer RM; Rose A; Mills PC
    Vet J; 2014 Feb; 199(2):229-35. PubMed ID: 24321367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT.
    Voors AA; van Veldhuisen DJ; Robertson M; Ford I; Borer JS; Böhm M; Komajda M; Swedberg K; Tavazzi L;
    Eur J Heart Fail; 2014 Apr; 16(4):426-34. PubMed ID: 24504937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of palmitoylethanolamide on endothelial dysfunction in ocular hypertensive patients: a randomized, placebo-controlled cross-over study.
    Strobbe E; Cellini M; Campos EC
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):968-73. PubMed ID: 23307959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).
    Goldfine AB; Buck JS; Desouza C; Fonseca V; Chen YD; Shoelson SE; Jablonski KA; Creager MA;
    Diabetes Care; 2013 Dec; 36(12):4132-9. PubMed ID: 24130358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Sahebkar A; Giua R; Pedone C; Ray KK; Vallejo-Vaz AJ; Costanzo L
    Pharmacol Res; 2016 Sep; 111():163-179. PubMed ID: 27320045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of endothelin blockade on acute exercise-induced changes in blood flow and endothelial function in type 2 diabetes mellitus.
    Schreuder TH; van Lotringen JH; Hopman MT; Thijssen DH
    Exp Physiol; 2014 Sep; 99(9):1253-64. PubMed ID: 24928953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of ivabradine vs atenolol on heart rate and effort tolerance in patients with mild to moderate mitral stenosis and normal sinus rhythm.
    Parakh N; Chaturvedi V; Kurian S; Tyagi S
    J Card Fail; 2012 Apr; 18(4):282-8. PubMed ID: 22464768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.
    Jochmann N; Schröter F; Knebel F; Hättasch R; Gericke C; Stangl K; Baumann G; Stangl V
    Cardiovasc Ultrasound; 2014 Jan; 12():5. PubMed ID: 24479706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of treatment with ivabradine and atenolol on reproducibility of echocardiographic indices of left heart size and function in healthy cats.
    Riesen SC; Schober KE; Cervenec RM; Bonagura JD
    J Vet Cardiol; 2012; 14(2):323-32. PubMed ID: 22578840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.
    Jedlickova L; Merkovska L; Jackova L; Janicko M; Fedacko J; Novakova B; Chmelarova A; Majernik J; Pella D
    Adv Ther; 2015 Oct; 32(10):962-70. PubMed ID: 26525390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pacemaker current inhibition in experimental human cardiac sympathetic activation: a double-blind, randomized, crossover study.
    Schroeder C; Heusser K; Zoerner AA; Großhennig A; Wenzel D; May M; Sweep FC; Mehling H; Luft FC; Tank J; Jordan J
    Clin Pharmacol Ther; 2014 Jun; 95(6):601-7. PubMed ID: 24509430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
    Böhm M; Robertson M; Ford I; Borer JS; Komajda M; Kindermann I; Maack C; Lainscak M; Swedberg K; Tavazzi L
    Am J Cardiol; 2015 Dec; 116(12):1890-7. PubMed ID: 26508709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.